NEW YORK (GenomeWeb) – Taconic Biosciences has signed a license agreement with ERS Genomics to use ERS' CRISPR-Cas9 technology to generate unique murine models.

Under the agreement, Taconic receives a worldwide, non-exclusive license to CRISPR-Cas9 intellectual property often referred to as the UC Berkeley patent. ERS founder Emmanuelle Charpentier is a co-inventor of the technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.